Search
Tackling resistance to HIF2 drugs with an RNA-based therapy: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/october-resistance-to-hif2-drugs.html
Expected to be diagnosed in 2% of men and 1% of women in the U.S., kidney cancer has traditionally been one of the most challenging cancers to treat.
Patient Notification: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2024/sept-patient-notification.html
UT Southwestern is notifying patients treated by UT Southwestern physicians of improper disclosure of protected health information.
UTSW Research: Alcohol-associated liver disease, depression treatment, and more: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2024/sept-research-roundup.html
Researchers have long known that outcomes for alcohol-associated liver disease (ALD) aren’t equal among all races and ethnicities in the U.S., but differences among these groups have been less clear.
Patient's satisfaction with doctor could influence decision to have bariatric surgery: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2023/february-bariatric-surgery.html
Patients’ satisfaction with their physicians may influence their decisions to undergo bariatric surgery, according to a multicenter study.
Fighting inflammatory bowel disease at its source: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/fighting-ibd.html
New findings on mechanism for intestinal inflammation could offer new targets for treating ulcerative colitis, Crohn’s disease, and other conditions
A powerhouse of obesity research – then and now: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2024/sept-obesity-research.html
As weight-loss drugs capture the public’s imagination, UTSW and its Nutrition Obesity Research Center are uniquely positioned to lead the way in discovery, education, and community outreach.
Common weight-loss drug successfully targets fat that can endanger heart health: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/obesity-drug.html
Researchers at UT Southwestern announced successful results of a clinical trial for a commonly prescribed weight-loss drug called liraglutide.
New findings expand genetic knowledge of autism underpinnings: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2024/dec-autism-underpinnings.html
Hundreds of novel genetic variants across an ancestrally diverse cohort of 195 families, including 222 people with autism spectrum disorder (ASD), have been identified by researchers at UT Southwestern Medical Center, expanding the catalog of known mutations associated with ASD.
Novel microscopy method at UT Southwestern provides look into future of cell biology: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/novel-microscopy-method.html
What if a microscope allowed us to explore the 3D microcosm of blood vessels, nerves, and cancer cells instantaneously in virtual reality?
3D-printed femurs may enhance biomechanical studies: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2024/oct-3d-printed-femurs.html
Researchers at UT Southwestern Medical Center have developed a breakthrough three-dimensional (3D) printing technique for generating realistic models of the human femur that could make it easier and less expensive to conduct biomechanical research.